Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Abernethy

Showing results (141-150 of 221) with videos related to

Pageof 23
Sort By:
Pharmacology|January 1, 1983
Determination of Ro 15-1788, a benzodiazepine antagonist, in human plasma by gas-liquid chromatography with nitrogen-phosphorus detection. Application to single-dose pharmacokinetic studiesD R Abernethy, R M Arendt, P M Lauven, et al.
Journal of Chromatography|October 14, 1983
Methods for the determination of lorazepam and chlordiazepoxide and metabolites in brain tissue. A comparison with plasma concentrations in the ratR G Lister, D R Abernethy, D J Greenblatt, et al.
Clinical Pharmacology and Therapeutics|February 1, 1984
Ranitidine does not impair oxidative or conjugative metabolism: noninteraction with antipyrine, diazepam, and lorazepamD R Abernethy, D J Greenblatt, F N Eshelman, et al.
Journal of Clinical Pharmacology|April 1, 1984
Interaction of cimetidine with oxazepam, lorazepam, and flurazepamD J Greenblatt, D R Abernethy, H H Koepke, et al.
British Journal of Clinical Pharmacology|April 1, 1985
An investigation of the cause of accumulation of verapamil during regular dosing in patientsJ B Schwartz, D R Abernethy, A A Taylor, et al.
The Journal of Membrane Biology|September 26, 2000
New molecular determinant for inactivation of the human L-type alpha1C Ca2+ channelN M Soldatov, S Zhenochin, B AlBanna, et al.
Clinical Pharmacology and Therapeutics|July 3, 1999
Regulating manufacturer-affiliated communication in the information ageK A Schulman, D R Abernethy, S S Rathore, et al.
Clinical Pharmacology and Therapeutics|May 22, 2012
Needs for an expanded ontology-based classification of adverse drug reactions and related mechanismsP E Zhichkin, B D Athey, M I Avigan, et al.
Molecular Pharmacology|December 18, 1998
Functional coupling of human L-type Ca2+ channels and angiotensin AT1A receptors coexpressed in xenopus laevis oocytes: involvement of the carboxyl-terminal Ca2+ sensorsM Oz, M T Melia, N M Soldatov, et al.
The Journal of Biological Chemistry|February 14, 1998
Molecular determinants of L-type Ca2+ channel inactivation. Segment exchange analysis of the carboxyl-terminal cytoplasmic motif encoded by exons 40-42 of the human alpha1C subunit geneN M Soldatov, M Oz, K A O'Brien, et al.
Pageof 23

Showing results (141-150 of 221) with videos related to

Sort By:
Pageof 23
Pharmacology|January 1, 1983
Determination of Ro 15-1788, a benzodiazepine antagonist, in human plasma by gas-liquid chromatography with nitrogen-phosphorus detection. Application to single-dose pharmacokinetic studiesD R Abernethy, R M Arendt, P M Lauven, et al.
Journal of Chromatography|October 14, 1983
Methods for the determination of lorazepam and chlordiazepoxide and metabolites in brain tissue. A comparison with plasma concentrations in the ratR G Lister, D R Abernethy, D J Greenblatt, et al.
Clinical Pharmacology and Therapeutics|February 1, 1984
Ranitidine does not impair oxidative or conjugative metabolism: noninteraction with antipyrine, diazepam, and lorazepamD R Abernethy, D J Greenblatt, F N Eshelman, et al.
Journal of Clinical Pharmacology|April 1, 1984
Interaction of cimetidine with oxazepam, lorazepam, and flurazepamD J Greenblatt, D R Abernethy, H H Koepke, et al.
British Journal of Clinical Pharmacology|April 1, 1985
An investigation of the cause of accumulation of verapamil during regular dosing in patientsJ B Schwartz, D R Abernethy, A A Taylor, et al.
The Journal of Membrane Biology|September 26, 2000
New molecular determinant for inactivation of the human L-type alpha1C Ca2+ channelN M Soldatov, S Zhenochin, B AlBanna, et al.
Clinical Pharmacology and Therapeutics|July 3, 1999
Regulating manufacturer-affiliated communication in the information ageK A Schulman, D R Abernethy, S S Rathore, et al.
Clinical Pharmacology and Therapeutics|May 22, 2012
Needs for an expanded ontology-based classification of adverse drug reactions and related mechanismsP E Zhichkin, B D Athey, M I Avigan, et al.
Molecular Pharmacology|December 18, 1998
Functional coupling of human L-type Ca2+ channels and angiotensin AT1A receptors coexpressed in xenopus laevis oocytes: involvement of the carboxyl-terminal Ca2+ sensorsM Oz, M T Melia, N M Soldatov, et al.
The Journal of Biological Chemistry|February 14, 1998
Molecular determinants of L-type Ca2+ channel inactivation. Segment exchange analysis of the carboxyl-terminal cytoplasmic motif encoded by exons 40-42 of the human alpha1C subunit geneN M Soldatov, M Oz, K A O'Brien, et al.
Pageof 23